Part of the Crohn's Disease Knowledge Library
Ulcerative Colitis (UC) and Crohn’s Disease (CD) are the two primary forms of Inflammatory Bowel Disease (IBD), chronic conditions characterized by inflammation of the gastrointestinal (GI) tract. Both conditions progress through stages that mark the disease’s evolution, each requiring distinct management strategies. Understanding these stages is crucial for early diagnosis, effective treatment, and improving patients’ quality of life. Additionally, incorporating Ayurvedic perspectives offers a holistic approach to managing these conditions.
Stages of Ulcerative Colitis and Crohn’s
Both UC and CD are autoimmune disorders where the immune system mistakenly attacks parts of the digestive tract, causing inflammation. While UC affects only the colon and rectum in a continuous manner, CD can impact any part of the GI tract from the mouth to the anus, often in patchy areas known as “skip lesions.”
Symptoms of both conditions include abdominal pain, diarrhea, weight loss, and fatigue. Risk factors for developing UC and CD include genetic predisposition, environmental factors, and an abnormal immune response. Smoking is a notable risk factor, particularly for CD.
The progression of UC is categorized into several stages, each with its own symptoms and treatment approaches:
Crohn’s Disease progresses through various stages, each with unique characteristics and treatment needs:
Ayurveda, an ancient system of medicine from India, provides a holistic approach to managing UC and CD by balancing the body’s doshas (Vata, Pitta, and Kapha), detoxifying the system, and improving digestion and immunity.
Combining modern medical practices with Ayurvedic principles provides a comprehensive approach to managing UC and CD. Early detection through colonoscopy, imaging, and blood tests can be complemented by Ayurvedic assessments for personalized treatment plans.
Understanding the stages of Ulcerative Colitis and Crohn’s Disease is essential for effective management and improving patients’ quality of life. Combining modern medical treatments with Ayurvedic practices offers a comprehensive and holistic approach. Through early diagnosis, tailored treatment plans, and integrative care, patients with UC and CD can achieve better health outcomes and an improved quality of life.
Love, J.R. ∙ Irvine, E.J. ∙ Fedorak, R.N. Quality of life in inflammatory bowel disease J Clin Gastroenterol. 1992; 14:15-19
Crossref Scopus (189) PubMed Google Scholar
Casellas, F. ∙ López-Vivancos, J. ∙ Vergara, M. … Impact of inflammatory bowel disease on health-related quality of life Dig Dis. 1999; 17:208-218
Crossref Scopus (90) PubMed Google Scholar
Van Assche, G. ∙ Peyrin-Biroulet, L. ∙ Sturm, A. … Burden of disease and patient-reported outcomes in patients with moderate to severe ulcerative colitis in the last 12 months – Multicenter European cohort study Dig Liver Dis. 2016; 48:592-600
Full Text Full Text (PDF) Scopus (37) PubMed Google Scholar
Mikocka-Walus, A. ∙ Pittet, V. ∙ Rossel, J.-B. … Symptoms of depression and anxiety are independently associated with clinical recurrence of inflammatory bowel disease Clin Gastroenterol Hepatol. 2016; 14:829-835.e1
Full Text Full Text (PDF) Scopus (258) PubMed Google Scholar
Tinsley, A. ∙ Macklin, E.A. ∙ Korzenik, J.R. … Validation of the functional assessment of chronic illness therapy-fatigue (FACIT-F) in patients with inflammatory bowel disease Aliment Pharmacol Ther. 2011; 34:1328-1336
Crossref Scopus (106) PubMed Google Scholar
Siebert, U. ∙ Wurm, J. ∙ Gothe, R.M. …Predictors of temporary and permanent work disability in patients with inflammatory bowel disease: results of the Swiss inflammatory bowel disease cohort study Inflamm Bowel Dis. 2013; 19:847-855
Crossref Scopus (48) PubMed Google Scholar
Høivik, M.L. ∙ Moum, B. ∙ Solberg, I.C. … Work disability in inflammatory bowel disease patients 10 years after disease onset: results from the IBSEN study Gut. 2013; 62:368-375
Crossref Scopus (192) PubMedGoogle Scholar
Gower-Rousseau, C. ∙ Sarter, H. ∙ Savoye, G. …Validation of the Inflammatory Bowel Disease Disability Index in a population-based cohort Gut. 2017; 66:588-596
Crossref copus (121) PubMed Google Scholar
Williet, N. ∙ Sarter, H. ∙ Gower-Rousseau, C. … Patient-reported outcomes in a French nationwide survey of inflammatory bowel disease patients J Crohns Colitis. 2017; 11:165-174
Crossref Scopus (115) PubMed Google Scholar
Fiorino, G. ∙ Bonifacio, C. ∙ Peyrin-Biroulet, L. … Preventing collateral damage in Crohn’s disease: the Lémann index
J Crohns Colitis. 2016; 10:495-500
Crossref Scopus (21) PubMed Google Scholar
Thia, K.T. ∙ Sandborn, W.J. ∙ Harmsen, W.S. … Risk factors associated with progression to intestinal complications of Crohn’s disease in a population-based cohort Gastroenterology. 2010; 139:1147-1155
Full Text Full Text (PDF) Scopus (593) PubMed Google Scholar
Fiorino, G. ∙ Bonifacio, C. ∙ Allocca, M. … Bowel damage as assessed by the Lémann index is reversible on anti-TNF therapy for Crohn’s disease J Crohns Colitis. 2015; 9:633-639
Crossref Scopus (61) PubMed Google Scholar
Meucci, G. ∙ Vecchi, M. ∙ Astegiano, M. … The natural history of ulcerative proctitis: a multicenter, retrospective study. Gruppo di Studio per le Malattie Infiammatorie Intestinali (GSMII) Am J Gastroenterol. 2000; 95:469-473
Crossref PubMed Google Scholar
Solberg, I.C. ∙ Lygren, I. ∙ Jahnsn, J. … Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study) Scand J Gastroenterol. 2009; 44:431-440
Crossref Scopus (586) PubMed Google Scholar
Medically reviewed by Dr. Adil Moulanchikkal, Lead Ayurveda Specialist at EliteAyurveda Clinics, with over 15 years of experience in treating neurological, skin, and autoimmune diseases.
Contact Us
At EliteAyurveda Specialist Clinic, we have a panel of specialists in various medical domains, including endocrine, autoimmune & dermatology. We are renowned for our multifaceted and root-cause approach to treating chronic and difficult-to-treat disorders.
Visit our website to learn more about individualized treatment plans based on Ayurvedic principles. Connect with us to get patient testimonials and speak directly with our patients about their experiences with our treatments.
Note: This article is for informational purposes only and is not a substitute for professional medical advice.
Related-
Know more About Ayurveda Treatment for colitis
Know more about ayurveda treatments for Crohn’s Disease
GET IN TOUCH
Medical disclaimer. This article is for general information and is not a substitute for personalised medical advice. Ayurvedic treatment at EliteAyurveda is individualised following clinical assessment. Do not start, stop or alter any prescribed medication without consulting your treating physician.